Outcome of children older than one year with neuroblastoma

Outcome of children older than one year with neuroblastoma

To assess the outcome of children older than one year with neuroblastoma treated at King Abdul-Aziz Medical City, Jeddah, Kingdom of Saudi Arabia. We retrospectively reviewed the files of 52 children older than one year with neuroblastoma (NBL) treated at our center between September 1987 and May 20...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neurosciences (Riyadh, Saudi Arabia) Saudi Arabia), 2008-01, Vol.13 (1), p.49-52
Hauptverfasser: Fayea, Najwa Y, Atra, Ayad A, Khattab, Taha, Elimam, Najla A, Felimban, Sami, Yousef, Abdelmoutaleb, Basheer, Ahmed, Zayed, Abdullah, Baothman, Abdullah, Al-Sheikh, Nada, Hussen, Wafa
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 52
container_issue 1
container_start_page 49
container_title Neurosciences (Riyadh, Saudi Arabia)
container_volume 13
creator Fayea, Najwa Y
Atra, Ayad A
Khattab, Taha
Elimam, Najla A
Felimban, Sami
Yousef, Abdelmoutaleb
Basheer, Ahmed
Zayed, Abdullah
Baothman, Abdullah
Al-Sheikh, Nada
Hussen, Wafa
description To assess the outcome of children older than one year with neuroblastoma treated at King Abdul-Aziz Medical City, Jeddah, Kingdom of Saudi Arabia. We retrospectively reviewed the files of 52 children older than one year with neuroblastoma (NBL) treated at our center between September 1987 and May 2003. Treatment consisted of OPEC chemotherapy regimen (vincristine, cisplatin, etoposide, and cyclophosphamide) or alternating OPEC/OJEC (carboplatin in place of cisplatin), surgical resection +/- radiotherapy (RT). No patient received high dose therapy (HDT). Thirty-four patients (65%) were stage 4, 12 (23%) stage 3, and 6 (11%) stage 2. Three stage 2 patients were treated with surgery only, all are alive in complete remission (CR). All stage 3 and 4 patients were treated with chemotherapy and surgery +/- RT. After induction chemotherapy, CR was achieved in 17 patients (32%) and partial remission in 10 (19%). Complete surgical resection was possible in 11 patients (22%). Disease recurrence or progression occurred in 27 patients (51%). With a median follow-up of 24 months (range 4-120), the 2-year event free survival was 10%, 82%, and 87% and the overall survival was 12%, 83%, and 100% for stage 4, 3, and 2. Children older than one year with localized NBL have good prognosis compared to those with stage 4. The use of HDT may improve the outcome in the latter group. Toxicity was significant, and adoption of risk-stratified treatment may help to reduce treatment complications.
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_763470981</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>763470981</sourcerecordid><originalsourceid>FETCH-LOGICAL-p210t-169f1e7e361a6e663617f5e4a12922f559c2363c1e459dc5f3580fa8dcecc3823</originalsourceid><addsrcrecordid>eNo1jz1rwzAYhDW0NCHNXyjaOhn8SpYsdSuhXxDIks5GkV9hF9lKJZmSf19B01vuhoc77oasgYOuJHC1ItuUvuoiUQTNHVkxqCVnSq7J02HJNkxIg6N2GH0fcabB9xhpHkyJM9ILmkh_xjzQGZcYTt6kHCZzT26d8Qm3V9-Qz9eX4-692h_ePnbP--pcZnIFUjvAFrkEI1HK4q0T2BhgmjEnhLaMS24BG6F7KxwXqnZG9Rat5YrxDXn86z3H8L1gyt00JovemxnDkrpW8qattYJCPlzJ5TRh353jOJl46f7v8l8NNE_N</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>763470981</pqid></control><display><type>article</type><title>Outcome of children older than one year with neuroblastoma</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>Fayea, Najwa Y ; Atra, Ayad A ; Khattab, Taha ; Elimam, Najla A ; Felimban, Sami ; Yousef, Abdelmoutaleb ; Basheer, Ahmed ; Zayed, Abdullah ; Baothman, Abdullah ; Al-Sheikh, Nada ; Hussen, Wafa</creator><creatorcontrib>Fayea, Najwa Y ; Atra, Ayad A ; Khattab, Taha ; Elimam, Najla A ; Felimban, Sami ; Yousef, Abdelmoutaleb ; Basheer, Ahmed ; Zayed, Abdullah ; Baothman, Abdullah ; Al-Sheikh, Nada ; Hussen, Wafa</creatorcontrib><description>To assess the outcome of children older than one year with neuroblastoma treated at King Abdul-Aziz Medical City, Jeddah, Kingdom of Saudi Arabia. We retrospectively reviewed the files of 52 children older than one year with neuroblastoma (NBL) treated at our center between September 1987 and May 2003. Treatment consisted of OPEC chemotherapy regimen (vincristine, cisplatin, etoposide, and cyclophosphamide) or alternating OPEC/OJEC (carboplatin in place of cisplatin), surgical resection +/- radiotherapy (RT). No patient received high dose therapy (HDT). Thirty-four patients (65%) were stage 4, 12 (23%) stage 3, and 6 (11%) stage 2. Three stage 2 patients were treated with surgery only, all are alive in complete remission (CR). All stage 3 and 4 patients were treated with chemotherapy and surgery +/- RT. After induction chemotherapy, CR was achieved in 17 patients (32%) and partial remission in 10 (19%). Complete surgical resection was possible in 11 patients (22%). Disease recurrence or progression occurred in 27 patients (51%). With a median follow-up of 24 months (range 4-120), the 2-year event free survival was 10%, 82%, and 87% and the overall survival was 12%, 83%, and 100% for stage 4, 3, and 2. Children older than one year with localized NBL have good prognosis compared to those with stage 4. The use of HDT may improve the outcome in the latter group. Toxicity was significant, and adoption of risk-stratified treatment may help to reduce treatment complications.</description><identifier>ISSN: 1319-6138</identifier><identifier>PMID: 21063286</identifier><language>eng</language><publisher>Saudi Arabia</publisher><ispartof>Neurosciences (Riyadh, Saudi Arabia), 2008-01, Vol.13 (1), p.49-52</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21063286$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fayea, Najwa Y</creatorcontrib><creatorcontrib>Atra, Ayad A</creatorcontrib><creatorcontrib>Khattab, Taha</creatorcontrib><creatorcontrib>Elimam, Najla A</creatorcontrib><creatorcontrib>Felimban, Sami</creatorcontrib><creatorcontrib>Yousef, Abdelmoutaleb</creatorcontrib><creatorcontrib>Basheer, Ahmed</creatorcontrib><creatorcontrib>Zayed, Abdullah</creatorcontrib><creatorcontrib>Baothman, Abdullah</creatorcontrib><creatorcontrib>Al-Sheikh, Nada</creatorcontrib><creatorcontrib>Hussen, Wafa</creatorcontrib><title>Outcome of children older than one year with neuroblastoma</title><title>Neurosciences (Riyadh, Saudi Arabia)</title><addtitle>Neurosciences (Riyadh)</addtitle><description>To assess the outcome of children older than one year with neuroblastoma treated at King Abdul-Aziz Medical City, Jeddah, Kingdom of Saudi Arabia. We retrospectively reviewed the files of 52 children older than one year with neuroblastoma (NBL) treated at our center between September 1987 and May 2003. Treatment consisted of OPEC chemotherapy regimen (vincristine, cisplatin, etoposide, and cyclophosphamide) or alternating OPEC/OJEC (carboplatin in place of cisplatin), surgical resection +/- radiotherapy (RT). No patient received high dose therapy (HDT). Thirty-four patients (65%) were stage 4, 12 (23%) stage 3, and 6 (11%) stage 2. Three stage 2 patients were treated with surgery only, all are alive in complete remission (CR). All stage 3 and 4 patients were treated with chemotherapy and surgery +/- RT. After induction chemotherapy, CR was achieved in 17 patients (32%) and partial remission in 10 (19%). Complete surgical resection was possible in 11 patients (22%). Disease recurrence or progression occurred in 27 patients (51%). With a median follow-up of 24 months (range 4-120), the 2-year event free survival was 10%, 82%, and 87% and the overall survival was 12%, 83%, and 100% for stage 4, 3, and 2. Children older than one year with localized NBL have good prognosis compared to those with stage 4. The use of HDT may improve the outcome in the latter group. Toxicity was significant, and adoption of risk-stratified treatment may help to reduce treatment complications.</description><issn>1319-6138</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNo1jz1rwzAYhDW0NCHNXyjaOhn8SpYsdSuhXxDIks5GkV9hF9lKJZmSf19B01vuhoc77oasgYOuJHC1ItuUvuoiUQTNHVkxqCVnSq7J02HJNkxIg6N2GH0fcabB9xhpHkyJM9ILmkh_xjzQGZcYTt6kHCZzT26d8Qm3V9-Qz9eX4-692h_ePnbP--pcZnIFUjvAFrkEI1HK4q0T2BhgmjEnhLaMS24BG6F7KxwXqnZG9Rat5YrxDXn86z3H8L1gyt00JovemxnDkrpW8qattYJCPlzJ5TRh353jOJl46f7v8l8NNE_N</recordid><startdate>200801</startdate><enddate>200801</enddate><creator>Fayea, Najwa Y</creator><creator>Atra, Ayad A</creator><creator>Khattab, Taha</creator><creator>Elimam, Najla A</creator><creator>Felimban, Sami</creator><creator>Yousef, Abdelmoutaleb</creator><creator>Basheer, Ahmed</creator><creator>Zayed, Abdullah</creator><creator>Baothman, Abdullah</creator><creator>Al-Sheikh, Nada</creator><creator>Hussen, Wafa</creator><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>200801</creationdate><title>Outcome of children older than one year with neuroblastoma</title><author>Fayea, Najwa Y ; Atra, Ayad A ; Khattab, Taha ; Elimam, Najla A ; Felimban, Sami ; Yousef, Abdelmoutaleb ; Basheer, Ahmed ; Zayed, Abdullah ; Baothman, Abdullah ; Al-Sheikh, Nada ; Hussen, Wafa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p210t-169f1e7e361a6e663617f5e4a12922f559c2363c1e459dc5f3580fa8dcecc3823</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fayea, Najwa Y</creatorcontrib><creatorcontrib>Atra, Ayad A</creatorcontrib><creatorcontrib>Khattab, Taha</creatorcontrib><creatorcontrib>Elimam, Najla A</creatorcontrib><creatorcontrib>Felimban, Sami</creatorcontrib><creatorcontrib>Yousef, Abdelmoutaleb</creatorcontrib><creatorcontrib>Basheer, Ahmed</creatorcontrib><creatorcontrib>Zayed, Abdullah</creatorcontrib><creatorcontrib>Baothman, Abdullah</creatorcontrib><creatorcontrib>Al-Sheikh, Nada</creatorcontrib><creatorcontrib>Hussen, Wafa</creatorcontrib><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Neurosciences (Riyadh, Saudi Arabia)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fayea, Najwa Y</au><au>Atra, Ayad A</au><au>Khattab, Taha</au><au>Elimam, Najla A</au><au>Felimban, Sami</au><au>Yousef, Abdelmoutaleb</au><au>Basheer, Ahmed</au><au>Zayed, Abdullah</au><au>Baothman, Abdullah</au><au>Al-Sheikh, Nada</au><au>Hussen, Wafa</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Outcome of children older than one year with neuroblastoma</atitle><jtitle>Neurosciences (Riyadh, Saudi Arabia)</jtitle><addtitle>Neurosciences (Riyadh)</addtitle><date>2008-01</date><risdate>2008</risdate><volume>13</volume><issue>1</issue><spage>49</spage><epage>52</epage><pages>49-52</pages><issn>1319-6138</issn><abstract>To assess the outcome of children older than one year with neuroblastoma treated at King Abdul-Aziz Medical City, Jeddah, Kingdom of Saudi Arabia. We retrospectively reviewed the files of 52 children older than one year with neuroblastoma (NBL) treated at our center between September 1987 and May 2003. Treatment consisted of OPEC chemotherapy regimen (vincristine, cisplatin, etoposide, and cyclophosphamide) or alternating OPEC/OJEC (carboplatin in place of cisplatin), surgical resection +/- radiotherapy (RT). No patient received high dose therapy (HDT). Thirty-four patients (65%) were stage 4, 12 (23%) stage 3, and 6 (11%) stage 2. Three stage 2 patients were treated with surgery only, all are alive in complete remission (CR). All stage 3 and 4 patients were treated with chemotherapy and surgery +/- RT. After induction chemotherapy, CR was achieved in 17 patients (32%) and partial remission in 10 (19%). Complete surgical resection was possible in 11 patients (22%). Disease recurrence or progression occurred in 27 patients (51%). With a median follow-up of 24 months (range 4-120), the 2-year event free survival was 10%, 82%, and 87% and the overall survival was 12%, 83%, and 100% for stage 4, 3, and 2. Children older than one year with localized NBL have good prognosis compared to those with stage 4. The use of HDT may improve the outcome in the latter group. Toxicity was significant, and adoption of risk-stratified treatment may help to reduce treatment complications.</abstract><cop>Saudi Arabia</cop><pmid>21063286</pmid><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1319-6138
ispartof Neurosciences (Riyadh, Saudi Arabia), 2008-01, Vol.13 (1), p.49-52
issn 1319-6138
language eng
recordid cdi_proquest_miscellaneous_763470981
source EZB-FREE-00999 freely available EZB journals
title Outcome of children older than one year with neuroblastoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T13%3A31%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Outcome%20of%20children%20older%20than%20one%20year%20with%20neuroblastoma&rft.jtitle=Neurosciences%20(Riyadh,%20Saudi%20Arabia)&rft.au=Fayea,%20Najwa%20Y&rft.date=2008-01&rft.volume=13&rft.issue=1&rft.spage=49&rft.epage=52&rft.pages=49-52&rft.issn=1319-6138&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E763470981%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=763470981&rft_id=info:pmid/21063286&rfr_iscdi=true